First Targeted Biologic for Bullous Pemphigoid Brings New Hope to Dermatology Practices
The FDA has approved Dupixent® (dupilumab) as the first and
June 24, 2025
The FDA has approved Dupixent® (dupilumab) as the first and
Dermatology is experiencing a notable shift: younger generations, specifically Millennials
Leading dermatology conferences, the South Beach Symposium and Masters of
When performed by a licensed dermatology provider in a medical
Sign up to receive updates on educational opportunities, complimentary content, exclusive discounts, and more.
LiVDerm / South Beach Symposium
1801 N Military Trail, Ste 110
Boca Raton, FL, 33431
Copyright © 2025, LiVDerm. All Rights Reserved.
Sign up to receive updates on educational opportunities, complimentary content, exclusive discounts, and more.
Sign up to receive updates on educational opportunities, complimentary content, exclusive discounts, and more.
